Codes and Coverage

Supporting patient access

BMS Access Support® may help support patient access by conducting benefits reviews and offering prior authorization and appeals process assistance for enrolled patients. Additionally, the information below provides product-specific billing and diagnosis codes, reimbursement and coding guides, distribution information, and additional coverage support offerings. To view available coding and coverage information, please select your patient’s prescribed medication.

Additional eligibility criteria and terms may apply. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

REVLIMID®

(lenalidomide)

The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.

Explore codes on this page:     ⬇NDC     ⬇ICD-10

National Drug Codes (NDC)1

Issued by the FDA

59572-0402-28 2.5 mg bottles of 28 capsules
59572-0402-00 2.5 mg bottles of 100 capsules
59572-0405-28 5 mg bottles of 28 capsules
59572-0405-00 5 mg bottles of 100 capsules
59572-0410-28 10 mg bottles of 28 capsules
59572-0410-00 10 mg bottles of 100 capsules
59572-0415-21 15 mg bottles of 21 capsules
59572-0415-00 15 mg bottles of 100 capsules
59572-0420-21 20 mg bottles of 21 capsules
59572-0420-00 20 mg bottles of 100 capsules
59572-0425-21 25 mg bottles of 21 capsules
59572-0425-00 25 mg bottles of 100 capsules
International Classification of Diseases, Tenth Revision, Clinical Modification Diagnosis Codes (ICD-10-CM)2

Coding for REVLIMID is dependent on the insurer and the care setting in which the drug will be administered. Oncology practices need to make coding decisions based on the diagnosis and treatment of each patient and the specific insurer requirements.

Please see U.S. Full Prescribing Information for REVLIMID, including Boxed WARNINGS.

*Healthcare providers should code healthcare claims based upon the service that is rendered, the patient’s medical record, the coding requirements of each health insurer, and best coding practices. Coding guidance provided under this heading does not provide a guarantee of reimbursement and should be considered together with all applicable coding guidance and standards. All of the coding information presented by this website is applicable to outpatient procedures only.

References:

  1. REVLIMID [package insert]. Princeton, NJ: Bristol-Myers Squibb Company.
  2. Centers for Medicare & Medicaid Services. ICD-10-CM tabular list of diseases and injuries. https://www.cms.gov/Medicare/Coding/ICD10/2023-ICD-10-CM. Accessed July 5, 2023.

Prescribers and pharmacies must be certified with the Lenalidomide REMS program by enrolling and complying with the REMS requirements; pharmacies must only dispense to patients who are authorized to receive REVLIMID. The REMS-Pharmacy Network list includes specialty pharmacies that are contracted to fill prescriptions for restricted distribution programs for Bristol Myers Squibb.

 

Specialty Pharmacies

Pharmacy Phone & Fax Orders
Absolute Pharmacy
Fax: 1-787-496-1010
AcariaHealth Pharmacy
Fax: 1-866-458-9245
Accredo Specialty Pharmacy
Fax: 1-800-590-1021
ACS Advanced Care Scripts
Fax: 1-866-679-7131
AllianceRx Walgreens Prime
Fax: 1-877-231-8302
Amber Specialty Pharmacy
Fax: 1-877-645-7514
Axium Healthcare Puerto Rico
Fax: 1-800-546-2163
Biologics by McKesson
Fax: 1-800-823-4506
Biomatrix
Fax: 1-877-800-4790
BioPlus Specialty Pharmacy
Fax: 1-800-269-5493
CareMed Specialty Pharmacy
Fax: 1-877-542-2731
CVS Specialty
Fax: 1-800-323-2445
Farmacia San Rafael
Fax: 1-787-721-4165
Humana Specialty Pharmacy
Fax: 1-877-405-7940
Kroger Specialty Pharmacy
Fax: 1-888-315-3270
Magellan Rx Pharmacy (ICORE)
Fax: 1-866-364-2673
Onco360
Fax: 1-877-662-6355
Optum Specialty Pharmacy
Fax: 1-866-306-5231
RxCrossroads by McKesson (VA Dispensing)
Fax: 1-855-637-9446
Special Care Pharmacy Services
Fax: 1-787-783-2951
Upstate Pharmacy
Phone: 1-800-314-4655
Fax: 1-800-314-7756
US Bioservices
Phone: 1-877-757-0667
Fax: 1-888-899-0067

Above information is accurate as of 01/26.

The REVLIMID distribution program includes extended payment terms to Bristol Myers Squibb authorized REVLIMID distributors. Healthcare providers and institutions should contact their REVLIMID distributor to understand specific payment terms that may be available to them from their distributor.

Please see U.S. Full Prescribing Information for REVLIMID, including Boxed WARNINGS.

 

FDA Approval Letters as Posted by the FDA:

Please see U.S. Full Prescribing Information for REVLIMID, including Boxed WARNINGS.

See Payer Policy Details

Learn about payer information by state for applicable treatments.